Security · CUSIP 03753UAB2
APELLIS PHARMACEUTICALS INC
NOTE 3.500% 9/1 · institutional ownership from 13F filings
13F holders
1
Shares held
0
Value held
$0
New / sold out
0 / 2
Added / reduced
0 / 0
net -6.0M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2024
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Opti Capital Management, LP | Sold out | -3,750,000 | -100.0% |
| LORD, ABBETT & CO. LLC | Sold out | -2,270,000 | -100.0% |